• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Selected Transactions


Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (47)

Deal Type

  • (298)
  • (141)
  • (140)
  • (7)

Clear all Apply

Bryan, Garnier & Co acts as European Lead Manager on Abivax’s USD 236 million Nasdaq IPO

Bryan, Garnier & Co acts as Financial Advisor to the Boiron Family in the €875m tender offer for the BOIRON Group, world leader in natural medicine, in partnership with EW Healthcare Partners

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Egetis Therapeutics on a Combined Offering of SEK 462m

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of RTS Group on its sale to Advania

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Nehs Digital and Xperis on their sale to Enovacom

Bryan, Garnier & Co acts as Sole Financial Advisor to Vulcain Engineering on the acquisition of iPlan Gestión Integral

Bryan, Garnier & Co acts as Sole Financial Advisor to rooom AG on its €17m fundraise led by Marondo Capital

Bryan, Garnier & Co acts as Sole Financial Advisor to Canon on the sale of Canon France Business Services to Paragon

Bryan, Garnier & Co acts as the Sole Financial Advisor to EKOSCAN INTEGRITY on its acquisition of AUT Solutions

Bryan, Garnier & Co acts as Sole Financial Advisor and Placement Agent to Abivax on two structured debt financing transactions for up to EUR 150 million

Bryan, Garnier & Co acts as Sole Financial Advisor to Verto (ex. NewAlpha Verto) and the Management of Sinari on a secondary LBO led by Bridgepoint Development Capital

Bryan, Garnier & Co acts as Sole Financial Advisor to Activa Capital and the Management of Explore Group on its sale to Intescia

  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 50

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }